참고문헌
- Andersson S, Mints M, Wilander E (2013). Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma. Oncol Lett, 6, 215-9.
- Arbyn M, Ronco G, Anttila A, et al (2012). Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine, 30, 88-99. https://doi.org/10.1016/j.vaccine.2012.06.095
- Ault KA, Joura EA, Kjaer SK, et al (2011). Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. Int J Cancer, 128, 1344-53. https://doi.org/10.1002/ijc.25723
- Bosch FX, Lorincz A, Muñoz N, et al (2001). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244-65.
- Ghosh I, Mittal S, Banerjee D, et al (2014). Study of accuracy of colposcopy in VIA and HPV detection-based cervical cancer screening program. Aust N Z J Obstet Gynaecol, 54, 570-5. https://doi.org/10.1111/ajo.12282
- Katki HA, Kinney WK, Fetterman B, et al (2011). Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a populationbased study in routine clinical practice. Lancet Oncol, 12, 663-72. https://doi.org/10.1016/S1470-2045(11)70145-0
- Kietpeerakool C, Srisomboon J, Prompittayarat W, et al (2006). Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization? Asian Pac J Cancer Prev, 7, 522-4.
- Paengchit K, Kietpeerakool C, Wangchai W, et al (2014). Cervical pathology in cytology-negative/HPV-positive women: results from Lampang Cancer Hospital, Thailand. Asian Pac J Cancer Prev, 15, 7951-54. https://doi.org/10.7314/APJCP.2014.15.18.7951
- Song Y, Zhao YQ, Zhang X, et al (2015). Random biopsy in colposcopy-negative quadrant is not effective in women with positive colposcopy in practice. Cancer Epidemiol, 39, 237-41. https://doi.org/10.1016/j.canep.2015.01.008
- Supho B, Supoken A, Kleebkaew P, et al (2014). Cervical pathology in high-risk human papillomavirus- positive, cytologically normal women. Asian Pac J Cancer Prev, 15, 7977-80. https://doi.org/10.7314/APJCP.2014.15.18.7977
- Saslow D, Solomon D, Lawson HW, et al (2012). American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin, 62, 147-72. https://doi.org/10.3322/caac.21139
- de Sanjose S, Quint WG, Alemany L, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11, 1048-56. https://doi.org/10.1016/S1470-2045(10)70230-8
- Siriaunkgul S, Suwiwat S, Settakorn J, et al (2008). HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol, 108, 555-60. https://doi.org/10.1016/j.ygyno.2007.11.016
- Thrall MJ, Russell DK, Facik MS, et al (2010). High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up. Am J Clin Pathol, 133, 894-8. https://doi.org/10.1309/AJCPAZV88VIFZSFD
- Wright TC Jr, Stoler MH, Behrens CM, et al (2012). The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol, 206, 1-46. https://doi.org/10.1016/j.ajog.2011.10.025
- Wright TC Jr, Stoler MH, Sharma A, et al (2011). Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. Am J Clin Pathol, 136, 578-86. https://doi.org/10.1309/AJCPTUS5EXAS6DKZ
- Yang B, Pretorius RG, Belinson JL, et al (2008). False negative colposcopy is associated with thinner cervical intraepithelial neoplasia 2 and 3. Gynecol Oncol, 110, 32-6 https://doi.org/10.1016/j.ygyno.2008.03.003